IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q3 2018 Holdings

Filed 2018-11-13 | 3 holdings | $125.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aegerion Pharmaceuticals IncNOTE 2.000% 8/100767EAB8$96.8K$133,337,00077.3%
PTC Therapeutics IncNOTE 3.000% 8/169366JAB7$26.6K$23,067,00021.2%
Apollo Endosurgery Inc(HQ8F)COM03767D108$1.8K252,0791.4%